Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Article in English | IMSEAR | ID: sea-148241

ABSTRACT

M. chelonae is a rare cause of human infection and is difficult to diagnose unless suspected for the same. A 55 year old healthy gynaecologist, diagnosed to have right inguinal hernia, underwent laparoscopic hernioplasty, after which he showed signs of post-operative wound infection which was confirmed to be due to M. chelonae. Definitive identification of this species of mycobacterium was possible by growth characteristics and biochemical tests. The organism was sensitive to Kanamycin, Clarithromycin, Ciprofloxacin and Amikacin. However, complete recovery from infection was possible after prolonged treatment with antibiotics to which the organism was sensitive.

2.
Indian J Med Microbiol ; 2003 Jan-Mar; 21(1): 59-60
Article in English | IMSEAR | ID: sea-53779

ABSTRACT

To the best of our knowledge, injection abscess due to Salmonella typhi has not been reported earlier. A patient with fever of unknown origin was diagnosed as suffering from typhoid fever, administered a course of ceftrioxone but patient developed an injection abscess due to S.typhi, abscess was drained and patient was started on ciprofloxacin to which he responded favourably.

3.
Article in English | IMSEAR | ID: sea-23874

ABSTRACT

Metallo beta-lactamase (MBL) producing Pseudomonas aeruginosa is an emerging threat and a cause of concern for the physicians treating such infections. The present study was undertaken to know the resistance pattern of P. aeruginosa to beta-lactamase inhibitors and carbapenems, and to detect the presence of MBL among resistant isolates to both groups of antibiotics. Between June-November 2001, 50 P. aeruginosa isolates from clinical specimens were tested for susceptibility to beta-lactamase inhibitors and carbapenems by Kirby-Bauer disc diffusion method. Isolates resistant to both groups of antibiotics were screened for the presence of MBLs by disc diffusion method using 2-mercaptoethanol. Of the 50 isolates, 6 (12%) were resistant to both beta-lactamase inhibitors and carbapenems. All 6 isolates were MBL producers were resistant to all the antibiotics tested. Resistance to piperacillin-tazobactam, cefoperazone-sulbactam and ticarcillin-clavulanic acid was 12, 20 and 36 per cent respectively. Resistance of 12 per cent each was noted to imipenem and meropenem respectively. This is to the best of our knowledge the first report of MBL producing P. aeruginosa from India and suggests the need for early detection, notification and control of spread.


Subject(s)
Anti-Bacterial Agents/pharmacology , Carbapenems/pharmacology , Drug Resistance, Bacterial , Enzyme Inhibitors/metabolism , Hospitalization , Humans , India , Pseudomonas Infections/drug therapy , Pseudomonas aeruginosa/drug effects , beta-Lactamases/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL